PC
PharmaCielo Ltd.
PCLOF · OTC
$0.04 -12.73% (-$0.01)
1M +0.70%
Market Cap $10.2M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.06
60.3% upside
Current Price
$0.037
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PCLOF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
61 /100
Fair P/S 2.84x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 21.15%
EPS growth N/A
FCF growth N/A
Profitability
13 /100
Weak Gross margin 33.80%
Net margin 103.20%
Op. margin 82.12%
Quality
5 /100
Poor ROIC 39.37%
ROA 29.18%
Asset turnover 0.28x
Debt
0 /100
High Current ratio 0.14x
Int. coverage -0.41x
Debt/Equity N/A
Stability
33 /100
Unstable Beta 1.06x
Rev. volatility 102.91%
EPS volatility 47.13%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PCLOF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Marc Lustig
Employees
268
Headquarters
Toronto
Upcoming events
26 NOV
Earnings
Upcoming earnings report